Results 71 to 80 of about 7,733 (241)

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature [PDF]

open access: yes, 2007
BACKGROUND: Eosinophilic fasciitis is a rare scleroderma-like illness. The clinical spectrum of the disease has evolved since its initial description. METHODS: We identified all patients diagnosed with eosinophilic fasciitis over the past 10 years at our
Bischoff, Lindsay, Derk, Chris T
core   +2 more sources

Vascular changes in morphea

open access: yesActa Dermato-Venereologica, 1985
Vascular changes in morphea were studied in skin biopsies from 14 patients. Small vessels with pericytes present the changes in three different patterns. The first was the endothelial cells in a stimulated condition and thickened vascular wall with infiltrating macrophages and mast cells.
T, Kobayasi, J, Serup
openaire   +2 more sources

Twardzina ograniczona pęcherzowa – przedstawienie dwóch przypadków, trudności terapeutyczne

open access: yesPrzegląd Dermatologiczny, 2011
tissue disease. The main symptoms are atrophy and fibrosis of the connectivetissue stroma, preceded by changes in the small blood vessels.Pathogenesis of morphea is still unknown.
Dorota Krasowska   +5 more
doaj  

Dermoscopy in general dermatology: A practical overview [PDF]

open access: yes, 2016
Over the last few years, dermoscopy has been shown to be a useful tool in assisting the noninvasive diagnosis of various general dermatological disorders.
Errichetti, Enzo, Stinco, Giuseppe
core   +1 more source

Fat Graft as Regenerative Treatment of Facial Manifestations of Systemic Sclerosis: A Systematic Review on the Role of Adipose Tissue‐Derived Stem Cells and on Surgical Outcomes to Define a New Standardised Injection Protocol

open access: yesWound Repair and Regeneration, Volume 33, Issue 3, May/June 2025.
ABSTRACT Facial symptoms of systemic sclerosis (SSc)—such as reduced skin elasticity, fibrosis and microstomy—significantly impact quality of life. In recent years, autologous fat grafting has emerged as a promising treatment for these issues, but determining the optimal timing and techniques for fat injection remains a challenge for surgeons.
A. Arena   +10 more
wiley   +1 more source

How I explore ... the skin functional involvement in scleroderma [PDF]

open access: yes, 2013
peer reviewedScleroderma refers to distinct clinical presentations sharing in common a sclerotic process most often clinically obvious on the skin. The involvement possibly affects the skin alone in morphea or in combination with internal lesions in ...
Andre, B.   +6 more
core  

Indurated Plaques in an Otherwise Healthy Child

open access: yes
Pediatric Dermatology, EarlyView.
Edan Davidson   +5 more
wiley   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi   +12 more
wiley   +1 more source

Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives

open access: yesExperimental Dermatology, Volume 34, Issue 4, April 2025.
ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Marco Spadafora   +5 more
wiley   +1 more source

Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study

open access: yesCase Reports in Dermatology, 2015
Both morphea and lichen sclerosus et atrophicus (LSA) are connective tissue diseases that mainly affect the skin. A recent report suggested that a substantial portion of morphea coexists with LSA.
Aya Kakizaki   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy